Who owns Ariad Pharmaceuticals?

Top Holders and Investors of ARIA Stock

Find out what company owns Ariad Pharmaceuticals, who bought ARIA this quarter, and who sold shares of ARIA stock?

Fund or Company Name Number of Shares Valued At As Of
BlackRock Fund Advisors 8.96M $111.46M Dec 2016
BlackRock Institutional Trust Company, N.A. 4.86M $60.49M Dec 2016
FNY Partners Fund 1.43M $34.30M Mar 2017
BlackRock Investment Management 667499 $8.30M Dec 2016
BlackRock Advisors 196087 $2.44M Dec 2016
E E Geduld 190900 $2.37M Dec 2016
BlackRock 166008 $2.07M Dec 2016
EverPoint Asset Management 45000 $559800 Dec 2016
Metlife Securities 13088 $142790 Dec 2016
BlackRock Japan 1769 $22006 Dec 2016

Who sold Ariad Pharmaceuticals?

Fund Name Date Sold Shares Held Valued At
Two Sigma Investments Dec. 31, 2016 1.83M $22.82M
Morgan Stanley Dec. 31, 2016 1.08M $13.39M
Two Sigma Advisers Dec. 31, 2016 568749 $7.08M
Royal Bank of Canada Dec. 31, 2016 47187 $584646
Tiaa Cref Trust Co Fsb/mo Dec. 31, 2016 30000 $372900
BlackRock Dec. 31, 2016 16920 $210654
Two Sigma Securities Dec. 31, 2016 15539 $192994